Article

Page 93

Posts about this type

Article

An Overview of the Treatment of Schizoaffective Disorder

May 1, 1999

Susan L. McElroy, Stephen M. Strakowski

Article

Patterns of Remission and Relapse in Obsessive-Compulsive Disorder: A 2-Year Prospective Study

May 1, 1999

Jane L. Eisen, Wayne K. Goodman, Martin B. Keller, et al

Article

Should We Consider Mood Disturbance in Schizophrenia as an Important Determinant of Quality of Life?

May 1, 1999

Gary D. Tollefson, Scott W. Andersen

Article

Tardive Dyskinesia in Affective Disorders

May 1, 1999

John M. Kane

Article

Night Terrors, Sleepwalking, and Confusional Arousals in the General Population: Their Frequency and Relationship to Other Sleep and Mental Disorders

April 30, 1999

Maurice M. Ohayon, Christian Guilleminault, Robert G. Priest

Article

Antidepressant Effectiveness in Severe Depression and Melancholia

April 1, 1999

Alan F. Schatzberg

Article

Depression in the Medical Setting: Biopsychological Interactions and Treatment Considerations

April 1, 1999

Dwight L. Evans, Jeffrey P. Staab, John M. Petitto, et al

Article

Introduction. Assessing Antidepressant Efficacy: A Reexamination

April 1, 1999

Dwight L. Evans

Article

Mechanism of Action of Antidepressant Medications

April 1, 1999

John P. Feighner

Article

How Should Efficacy Be Evaluated in Randomized Clinical Trials of Treatments for Depression?

April 1, 1999

Michael E. Thase

Article

SSRIs and SNRIs: Broad Spectrum of Efficacy Beyond Major Depression

April 1, 1999

Jack M. Gorman, Justine M. Kent

Article

Treatment Options for Refractory Depression

April 1, 1999

Richard C. Shelton

Article

Suicide Victims With Schizophrenia in Different Treatment Phases and Adequacy of Antipsychotic Medication

March 31, 1999

Hannele Heila, Erkki T. Isometsä, Markus M. Henriksson, et al

Article

Concluding Discussion: Pharmacoeconomic Factors Related to the Treatment of Schizophrenia

March 1, 1999

Article

Cost of Treating Mental Illness From a Managed Care Perspective

March 1, 1999

John P. Docherty

Article

Cost-Utility Analysis in Schizophrenia

March 1, 1999

A. George Awad, Lakshmi P. Voruganti

Article

Mental Health Care From the Public Perspective: The Texas Medication Algorithm Project

March 1, 1999

Steven P. Shon, M. Lynn Crismon, Marcia G. Toprac, et al

Article

Methods of Cost-Effectiveness Analysis in the Evaluation of New Antipsychotics: Implications for Schizophrenia Treatment

March 1, 1999

Peter J. Neumann

Article

Panel on Cost-Effectiveness in Health and Medicine Recommendations: Identifying Costs

March 1, 1999

Willard G. Manning, Jr.

Article

What About the Patient?

March 1, 1999

Daniel E. Weisburd

Article

Perspective and the Measurement of Costs and Benefits for Cost-Effectiveness Analysis in Schizophrenia

March 1, 1999

David Meltzer

Article

The Risperidone Outcomes Study of Effectiveness (ROSE): A Model for Evaluating Treatment Strategies in Typical Psychiatric Practice

March 1, 1999

Ramy Mahmoud, Luella Engelhart, Dan Ollendorf, et al

Article

The Wisconsin Quality of Life Index: A Multidimensional Model for Measuring Quality of Life

March 1, 1999

Ronald Diamond, Marion Becker

Article

Fertility and Reproduction in Women With Anorexia Nervosa: A Controlled Study

February 28, 1999

Cynthia M. Bulik, Patrick F. Sullivan, Jennifer L. Fear, et al

« 1 … 91 92 93 94 95 … 107 »

Article

An Overview of the Treatment of Schizoaffective Disorder

Patterns of Remission and Relapse in Obsessive-Compulsive Disorder: A 2-Year Prospective Study

Should We Consider Mood Disturbance in Schizophrenia as an Important Determinant of Quality of Life?

Tardive Dyskinesia in Affective Disorders

Night Terrors, Sleepwalking, and Confusional Arousals in the General Population: Their Frequency and Relationship to Other Sleep and Mental Disorders

Antidepressant Effectiveness in Severe Depression and Melancholia

Depression in the Medical Setting: Biopsychological Interactions and Treatment Considerations

Introduction. Assessing Antidepressant Efficacy: A Reexamination

Mechanism of Action of Antidepressant Medications

How Should Efficacy Be Evaluated in Randomized Clinical Trials of Treatments for Depression?

SSRIs and SNRIs: Broad Spectrum of Efficacy Beyond Major Depression

Treatment Options for Refractory Depression

Suicide Victims With Schizophrenia in Different Treatment Phases and Adequacy of Antipsychotic Medication

Concluding Discussion: Pharmacoeconomic Factors Related to the Treatment of Schizophrenia

Cost of Treating Mental Illness From a Managed Care Perspective

Cost-Utility Analysis in Schizophrenia

Mental Health Care From the Public Perspective: The Texas Medication Algorithm Project

Methods of Cost-Effectiveness Analysis in the Evaluation of New Antipsychotics: Implications for Schizophrenia Treatment

Panel on Cost-Effectiveness in Health and Medicine Recommendations: Identifying Costs

What About the Patient?

Perspective and the Measurement of Costs and Benefits for Cost-Effectiveness Analysis in Schizophrenia

The Risperidone Outcomes Study of Effectiveness (ROSE): A Model for Evaluating Treatment Strategies in Typical Psychiatric Practice

The Wisconsin Quality of Life Index: A Multidimensional Model for Measuring Quality of Life

Fertility and Reproduction in Women With Anorexia Nervosa: A Controlled Study

ELSEWHERE:

FOLLOW US:

Article

Posts about this type

An Overview of the Treatment of Schizoaffective Disorder

Patterns of Remission and Relapse in Obsessive-Compulsive Disorder: A 2-Year Prospective Study

Should We Consider Mood Disturbance in Schizophrenia as an Important Determinant of Quality of Life?

Tardive Dyskinesia in Affective Disorders

Night Terrors, Sleepwalking, and Confusional Arousals in the General Population: Their Frequency and Relationship to Other Sleep and Mental Disorders

Antidepressant Effectiveness in Severe Depression and Melancholia

Depression in the Medical Setting: Biopsychological Interactions and Treatment Considerations

Introduction. Assessing Antidepressant Efficacy: A Reexamination

Mechanism of Action of Antidepressant Medications

How Should Efficacy Be Evaluated in Randomized Clinical Trials of Treatments for Depression?

SSRIs and SNRIs: Broad Spectrum of Efficacy Beyond Major Depression

Treatment Options for Refractory Depression

Suicide Victims With Schizophrenia in Different Treatment Phases and Adequacy of Antipsychotic Medication

Concluding Discussion: Pharmacoeconomic Factors Related to the Treatment of Schizophrenia

Cost of Treating Mental Illness From a Managed Care Perspective

Cost-Utility Analysis in Schizophrenia

Mental Health Care From the Public Perspective: The Texas Medication Algorithm Project

Methods of Cost-Effectiveness Analysis in the Evaluation of New Antipsychotics: Implications for Schizophrenia Treatment

Panel on Cost-Effectiveness in Health and Medicine Recommendations: Identifying Costs

What About the Patient?

Perspective and the Measurement of Costs and Benefits for Cost-Effectiveness Analysis in Schizophrenia

The Risperidone Outcomes Study of Effectiveness (ROSE): A Model for Evaluating Treatment Strategies in Typical Psychiatric Practice

The Wisconsin Quality of Life Index: A Multidimensional Model for Measuring Quality of Life

Fertility and Reproduction in Women With Anorexia Nervosa: A Controlled Study

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles